AnaptysBio Inc (ANAB) — Cash Flow Reinvestment Rate
AnaptysBio Inc (ANAB) has a Cash Flow Reinvestment Rate of 0.75x as of December 2025, reinvesting $73.50 Million (capex $1.00K plus investments $73.50 Million) from operating cash flow of $98.00 Million. See ANAB free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
AnaptysBio Inc Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for AnaptysBio Inc across 2 annual periods. For the full cash flow conversion analysis, see ANAB cash flow conversion.
Annual Cash Flow Reinvestment Rate for AnaptysBio Inc (2014–2025)
Year-by-year capital reinvestment analysis for AnaptysBio Inc. See ANAB FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 11.59x | $228.21 Million | $19.70 Million | $87.00K | ▼ -30.4% |
| 2014 | 16.63x | $242.91 Million | $14.60 Million | $145.00K | — |